AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $3.648M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| LVE | Quarterly Update & Appendix 4C | PRICE SENSITIVE | 24/04/18 | |
| LVE | Initial Director's Interest Notice | 01/02/18 | ||
| LVE | Board changes | 01/02/18 | ||
| LVE Quarterly Update & Appendix 4C | |||
| 24/04/18 | PRICE SENSITIVE | ||
| LVE Initial Director's Interest Notice | |||
| 01/02/18 | |||
| LVE Board changes | |||
| 01/02/18 | |||
